Your browser doesn't support javascript.
loading
No vaccine interference between bovine coronavirus and bovine herpesvirus-1 in a randomized trial when coadministrating two intranasal modified-live viral vaccines to neonatal calves.
Bolton, Michael W; Nordstrom, Scott; Hill, Kevin; Midla, Lowell; Rajamanikam, Karthic; Griebel, Philip J.
Afiliación
  • Bolton MW; Merck Animal Health, Rahway, NJ.
  • Nordstrom S; Merck Animal Health, Rahway, NJ.
  • Hill K; Merck Animal Health, Rahway, NJ.
  • Midla L; Merck Animal Health, Rahway, NJ.
  • Rajamanikam K; Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK, Canada.
  • Griebel PJ; Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK, Canada.
Am J Vet Res ; 85(5)2024 May 01.
Article en En | MEDLINE | ID: mdl-38457927
ABSTRACT

OBJECTIVE:

Compare immune responses induced by 2 commercial intranasal (IN) modified-live viral (MLV) vaccines given individually or coadministered and evaluate prevention of infection and lung pathology following bovine herpesvirus-1 (BHV-1) challenge. ANIMALS 36 male Holstein calves (ages, 5 to 12 days).

METHODS:

In a randomized complete block design, each calf received an IN injection of either vaccine diluent (Placebo), an MLV vaccine containing bovine herpesvirus-1 (BHV-1; N3), bovine coronavirus vaccine (BC), or both N3 and BC (BC + N3) with a booster 4 weeks later. Nasal secretions and blood were collected weekly. Three weeks after the booster, the calves were challenged with BHV-1, sampled for virus shedding, and euthanized 10 days later to quantify lung pathology. The study period was September 7, 2020, to April 6, 2021.

RESULTS:

Calves were seropositive for BHV-1 and BC before vaccination. No significant difference in BC-specific serum immunoglobin G and nasal immunoglobin A antibody responses in the BC versus BC + N3 group or BHV-1-specific serum immunoglobin G and nasal immunoglobin A antibody responses in the N3 versus BC + N3 group. Cytokine responses to BHV-1 and BC did not differ among groups. BHV-1 shedding after challenge was significantly reduced in N3 groups versus Placebo and BC. There was a significant reduction in lung pathology in the N3 + BC group versus Placebo. CLINICAL RELEVANCE This study provides evidence an MLV vaccine containing BHV-1 and an MLV BC vaccine can be coadministered to neonatal calves without significantly altering immune responses to the 2 viruses or compromising the prevention of BHV-1 respiratory disease. Calves receiving the BC + N3 vaccine had a significant reduction in lung pathology after BHV-1 aerosol challenge.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Administración Intranasal / Vacunas Atenuadas / Vacunas Virales / Enfermedades de los Bovinos / Coronavirus Bovino / Infecciones por Coronavirus / Infecciones por Herpesviridae / Herpesvirus Bovino 1 / Animales Recién Nacidos Límite: Animals Idioma: En Revista: Am J Vet Res Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Administración Intranasal / Vacunas Atenuadas / Vacunas Virales / Enfermedades de los Bovinos / Coronavirus Bovino / Infecciones por Coronavirus / Infecciones por Herpesviridae / Herpesvirus Bovino 1 / Animales Recién Nacidos Límite: Animals Idioma: En Revista: Am J Vet Res Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos